SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response: 0.5

1. Name and Address of Reporting Person* Lilly Kevin C (Last) (First) (Middle) 2645 SILVER CRESCENT DRIVE (Street) CHARLOTTE NC 28273 (City) (State) (Zip)	2. Date of Event Requiring Statement (Month/Day/Year) 07/28/2022	3. Issuer Name and Ticker or Trading Symbol JELD-WEN Holding, Inc. [ JELD ]
		4. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director 10% Owner X Officer (give title below) Other (specify below) Interim CEO	5. If Amendment, Date of Original Filed (Month/Day/Year)
			6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	43,589(1)	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Common Stock Option (Right to Buy)	(2)	02/25/2029	Common Stock	4,501	$20.96	D
Common Stock Option (Right to Buy)	(3)	02/11/2030	Common Stock	7,936	$24.54	D
Common Stock Option (Right to Buy)	(3)	02/23/2031	Common Stock	10,240	$29.01	D
Common Stock Option (Right to Buy)	(3)	02/16/2032	Common Stock	12,416	$24.17	D

Explanation of Responses:

1. The reported transaction includes the following awards made in respect of the issuer's common stock, the vesting of which is subject to the reporting person's continued employment with the issuer: (i) 3,056 restricted stock units granted on February 11, 2020, which shall vest on February 11, 2023, (ii) 5,687 restricted stock units granted on February 23, 2021, which shall vest on February 23, 2024, (iii) 5,079 restricted stock units granted on February 23, 2021, which shall vest one-third annually over a three-year period beginning on the first anniversary of the grant date, and (iv) 28,899 restricted stock units granted on February 16, 2022, which shall vest one-third annually over a three-year period beginning on the first anniversary of the grant date.

2. The options vested fully on February 25, 2022.

3. Subject to the reporting person's continued employment with the issuer, the options will vest one-third annually over a three-year period beginning on the first anniversary of the grant date.

Remarks:

	/s/ Roya Behnia as attorney-in-fact for Kevin C Lilly	08/05/2022
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.